RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 70 filers reported holding RA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $294,724,000 | +2.3% | 6,138,797 | 0.0% | 15.40% | +13.0% |
Q4 2019 | $288,094,000 | +98.4% | 6,138,797 | 0.0% | 13.62% | +13.3% |
Q3 2019 | $145,183,000 | -21.4% | 6,138,797 | 0.0% | 12.02% | -7.0% |
Q2 2019 | $184,594,000 | +34.2% | 6,138,797 | 0.0% | 12.93% | +81.1% |
Q1 2019 | $137,509,000 | +23.1% | 6,138,797 | 0.0% | 7.14% | +61.1% |
Q4 2018 | $111,726,000 | +12.4% | 6,138,797 | +11.7% | 4.43% | +3.3% |
Q3 2018 | $99,380,000 | +81.8% | 5,493,636 | 0.0% | 4.29% | +67.4% |
Q2 2018 | $54,662,000 | +87.4% | 5,493,636 | 0.0% | 2.56% | +97.3% |
Q1 2018 | $29,171,000 | -1.8% | 5,493,636 | +57.2% | 1.30% | +5.5% |
Q4 2017 | $29,696,000 | -41.8% | 3,493,636 | 0.0% | 1.23% | -31.2% |
Q3 2017 | $51,007,000 | -22.1% | 3,493,636 | 0.0% | 1.79% | -25.0% |
Q2 2017 | $65,471,000 | -12.0% | 3,493,636 | 0.0% | 2.38% | -7.9% |
Q1 2017 | $74,380,000 | +40.2% | 3,493,636 | 0.0% | 2.59% | +22.6% |
Q4 2016 | $53,068,000 | – | 3,493,636 | – | 2.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|